In Conversation: Can psychedelics rewire the depressed, anxious brain?

As part of Mental Health Awareness month, Dr. Hilary Guite discusses the neuroscience behind anxiety and depression with Dr. Jacques Ambrose, the director of Columbia University’s Irving Medical Center. They also consider the effects of existing and new treatment approaches, such as psychedelic drugs and ketamine. For this conversation, Hilary is also joined by Olivia, who has long-standing anxiety and depression, and Yasemin Nicola Sakay, Medical News Today’s global news editor.